TY  - GEN
AU  - Hesselbjerg,Louise Justesen
AU  - Pedersen,Heidi Sjoelund
AU  - Asmussen,Mikael Bergholdt
AU  - Petersen,Karin Dam
TI  - Is dabigatran considered a cost-effective alternative to warfarin treatment: a review of current economic evaluations worldwide
SN  - 1941-837X
PY  - 2014///0303
KW  - Anticoagulants
KW  - adverse effects
KW  - Atrial Fibrillation
KW  - drug therapy
KW  - Benzimidazoles
KW  - administration & dosage
KW  - Cost-Benefit Analysis
KW  - Dabigatran
KW  - Embolism
KW  - prevention & control
KW  - Hemorrhage
KW  - chemically induced
KW  - Humans
KW  - Quality-Adjusted Life Years
KW  - Stroke
KW  - Warfarin
KW  - beta-Alanine
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.3111/13696998.2013.800523
ER  -